Skip to main content

Replimune Group, Inc.

REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001737953

In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Replimune Group, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of REPL: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders102106+4
Shares40.0M40.8M+761.2K (+1.9%)
Value$700.2M$703.9M+$3.73M (+0.5%)

New holders (12)

Institutions that held Replimune Group, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to REPL in Q3 2022
InstitutionSharesValue% of portfolio
T. Rowe Price Investment Management, Inc.1,226,870$21.2M0.02%
Great Point Partners LLC390,000$6.74M1.62%
Ameriprise Financial Inc216,669$3.74M0.00%
Fisher Asset Management, LLC55,258$954.0K0.00%
Susquehanna International Group, LLP42,103$727.0K0.00%
Mirae Asset Global Investments Co., Ltd.13,720$237.0K0.00%
ExodusPoint Capital Management, LP13,578$234.0K0.00%
Campbell & CO Investment Adviser LLC12,022$208.0K0.05%
UBS Asset Management Americas Inc11,739$202.7K0.00%
China Universal Asset Management Co., Ltd.462$8.00K0.00%
Allworth Financial LP13$00.00%
Covestor Ltd5$00.00%

Sold out (8)

Institutions that held Replimune Group, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of REPL in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Bank of Montreal215,930$3.78M
Gsa Capital Partners LLP59,430$1.04M
Squarepoint Ops LLC31,434$549.0K
Quantbot Technologies LP5,980$104.0K
Charter Oak Capital Management, LLC200$3.00K
State of Wyoming137$2.00K
Dark Forest Capital Management LP5$0
Federated Hermes, Inc.3–